<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;utm_medium=rss
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;utm_medium=rss" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Sat, 25 May 2024 00:39:46 +0000</lastbuilddate>
<pubDate>Fri, 24 May 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Taking the sex out of atrial fibrillation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38788131/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 24:ehae256. doi: 10.1093/eurheartj/ehae256. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38788131/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38788131</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae256>10.1093/eurheartj/ehae256</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38788131</guid>
<pubDate>Fri, 24 May 2024 06:00:00 -0400</pubDate>
<dc:creator>David Brieger</dc:creator>
<dc:creator>Ben Freedman</dc:creator>
<dc:date>2024-05-24</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Taking the sex out of atrial fibrillation</dc:title>
<dc:identifier>pmid:38788131</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae256</dc:identifier>
</item>
<item>
<title>A hidden cause of middle-aged onset heart failure with preserved ejection fraction: a GTPBP3 variant</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38785384/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 24:ehae309. doi: 10.1093/eurheartj/ehae309. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38785384/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38785384</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae309>10.1093/eurheartj/ehae309</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38785384</guid>
<pubDate>Fri, 24 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Toshiyuki Yano</dc:creator>
<dc:creator>Atsuhito Takeda</dc:creator>
<dc:creator>Kei Murayama</dc:creator>
<dc:date>2024-05-24</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>A hidden cause of middle-aged onset heart failure with preserved ejection fraction: a GTPBP3 variant</dc:title>
<dc:identifier>pmid:38785384</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae309</dc:identifier>
</item>
<item>
<title>Peptide REF1 is a local wound signal promoting plant regeneration</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38781969/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>Plants frequently encounter wounding and have evolved an extraordinary regenerative capacity to heal the wounds. However, the wound signal that triggers regenerative responses has not been identified. Here, through characterization of a tomato mutant defective in both wound-induced defense and regeneration, we demonstrate that in tomato, a plant elicitor peptide (Pep), REGENERATION FACTOR1 (REF1), acts as a systemin-independent local wound signal that primarily regulates local defense responses...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 14:S0092-8674(24)00466-5. doi: 10.1016/j.cell.2024.04.040. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Plants frequently encounter wounding and have evolved an extraordinary regenerative capacity to heal the wounds. However, the wound signal that triggers regenerative responses has not been identified. Here, through characterization of a tomato mutant defective in both wound-induced defense and regeneration, we demonstrate that in tomato, a plant elicitor peptide (Pep), REGENERATION FACTOR1 (REF1), acts as a systemin-independent local wound signal that primarily regulates local defense responses and regenerative responses in response to wounding. We further identified PEPR1/2 ORTHOLOG RECEPTOR-LIKE KINASE1 (PORK1) as the receptor perceiving REF1 signal for plant regeneration. REF1-PORK1-mediated signaling promotes regeneration via activating WOUND-INDUCED DEDIFFERENTIATION 1 (WIND1), a master regulator of wound-induced cellular reprogramming in plants. Thus, REF1-PORK1 signaling represents a conserved phytocytokine pathway to initiate, amplify, and stabilize a signaling cascade that orchestrates wound-triggered organ regeneration. Application of REF1 provides a simple method to boost the regeneration and transformation efficiency of recalcitrant crops.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38781969/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38781969</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.040>10.1016/j.cell.2024.04.040</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38781969</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Wentao Yang</dc:creator>
<dc:creator>Huawei Zhai</dc:creator>
<dc:creator>Fangming Wu</dc:creator>
<dc:creator>Lei Deng</dc:creator>
<dc:creator>Yu Chao</dc:creator>
<dc:creator>Xianwen Meng</dc:creator>
<dc:creator>Qian Chen</dc:creator>
<dc:creator>Chenhuan Liu</dc:creator>
<dc:creator>Xiaomin Bie</dc:creator>
<dc:creator>Chuanlong Sun</dc:creator>
<dc:creator>Yang Yu</dc:creator>
<dc:creator>Xiaofei Zhang</dc:creator>
<dc:creator>Xiaoyue Zhang</dc:creator>
<dc:creator>Zeqian Chang</dc:creator>
<dc:creator>Min Xue</dc:creator>
<dc:creator>Yajie Zhao</dc:creator>
<dc:creator>Xiangbing Meng</dc:creator>
<dc:creator>Boshu Li</dc:creator>
<dc:creator>Xiansheng Zhang</dc:creator>
<dc:creator>Dajian Zhang</dc:creator>
<dc:creator>Xiangyu Zhao</dc:creator>
<dc:creator>Caixia Gao</dc:creator>
<dc:creator>Jiayang Li</dc:creator>
<dc:creator>Chuanyou Li</dc:creator>
<dc:date>2024-05-23</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Peptide REF1 is a local wound signal promoting plant regeneration</dc:title>
<dc:identifier>pmid:38781969</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.040</dc:identifier>
</item>
<item>
<title>Rapid DNA unwinding accelerates genome editing by engineered CRISPR-Cas9</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38781968/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>Thermostable clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas9) enzymes could improve genome-editing efficiency and delivery due to extended protein lifetimes. However, initial experimentation demonstrated Geobacillus stearothermophilus Cas9 (GeoCas9) to be virtually inactive when used in cultured human cells. Laboratory-evolved variants of GeoCas9 overcome this natural limitation by acquiring mutations in the wedge (WED) domain that produce...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 13:S0092-8674(24)00457-4. doi: 10.1016/j.cell.2024.04.031. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Thermostable clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas9) enzymes could improve genome-editing efficiency and delivery due to extended protein lifetimes. However, initial experimentation demonstrated Geobacillus stearothermophilus Cas9 (GeoCas9) to be virtually inactive when used in cultured human cells. Laboratory-evolved variants of GeoCas9 overcome this natural limitation by acquiring mutations in the wedge (WED) domain that produce >;100-fold-higher genome-editing levels. Cryoelectron microscopy (cryo-EM) structures of the wild-type and improved GeoCas9 (iGeoCas9) enzymes reveal extended contacts between the WED domain of iGeoCas9 and DNA substrates. Biochemical analysis shows that iGeoCas9 accelerates DNA unwinding to capture substrates under the magnesium-restricted conditions typical of mammalian but not bacterial cells. These findings enabled rational engineering of other Cas9 orthologs to enhance genome-editing levels, pointing to a general strategy for editing enzyme improvement. Together, these results uncover a new role for the Cas9 WED domain in DNA unwinding and demonstrate how accelerated target unwinding dramatically improves Cas9-induced genome-editing activity.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38781968/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38781968</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.031>10.1016/j.cell.2024.04.031</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38781968</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Amy R Eggers</dc:creator>
<dc:creator>Kai Chen</dc:creator>
<dc:creator>Katarzyna M Soczek</dc:creator>
<dc:creator>Owen T Tuck</dc:creator>
<dc:creator>Erin E Doherty</dc:creator>
<dc:creator>Bryant Xu</dc:creator>
<dc:creator>Marena I Trinidad</dc:creator>
<dc:creator>Brittney W Thornton</dc:creator>
<dc:creator>Peter H Yoon</dc:creator>
<dc:creator>Jennifer A Doudna</dc:creator>
<dc:date>2024-05-23</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Rapid DNA unwinding accelerates genome editing by engineered CRISPR-Cas9</dc:title>
<dc:identifier>pmid:38781968</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.031</dc:identifier>
</item>
<item>
<title>Patterning and folding of intestinal villi by active mesenchymal dewetting</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38781967/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>Tissue folds are structural motifs critical to organ function. In the intestine, bending of a flat epithelium into a periodic pattern of folds gives rise to villi, finger-like protrusions that enable nutrient absorption. However, the molecular and mechanical processes driving villus morphogenesis remain unclear. Here, we identify an active mechanical mechanism that simultaneously patterns and folds the intestinal epithelium to initiate villus formation. At the cellular level, we find that...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 20:S0092-8674(24)00465-3. doi: 10.1016/j.cell.2024.04.039. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Tissue folds are structural motifs critical to organ function. In the intestine, bending of a flat epithelium into a periodic pattern of folds gives rise to villi, finger-like protrusions that enable nutrient absorption. However, the molecular and mechanical processes driving villus morphogenesis remain unclear. Here, we identify an active mechanical mechanism that simultaneously patterns and folds the intestinal epithelium to initiate villus formation. At the cellular level, we find that PDGFRA+ subepithelial mesenchymal cells generate myosin II-dependent forces sufficient to produce patterned curvature in neighboring tissue interfaces. This symmetry-breaking process requires altered cell and extracellular matrix interactions that are enabled by matrix metalloproteinase-mediated tissue fluidization. Computational models, together with in vitro and in vivo experiments, revealed that these cellular features manifest at the tissue level as differences in interfacial tensions that promote mesenchymal aggregation and interface bending through a process analogous to the active dewetting of a thin liquid film.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38781967/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38781967</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.039>10.1016/j.cell.2024.04.039</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38781967</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Tyler R Huycke</dc:creator>
<dc:creator>Teemu J Häkkinen</dc:creator>
<dc:creator>Hikaru Miyazaki</dc:creator>
<dc:creator>Vasudha Srivastava</dc:creator>
<dc:creator>Emilie Barruet</dc:creator>
<dc:creator>Christopher S McGinnis</dc:creator>
<dc:creator>Ali Kalantari</dc:creator>
<dc:creator>Jake Cornwall-Scoones</dc:creator>
<dc:creator>Dedeepya Vaka</dc:creator>
<dc:creator>Qin Zhu</dc:creator>
<dc:creator>Hyunil Jo</dc:creator>
<dc:creator>Roger Oria</dc:creator>
<dc:creator>Valerie M Weaver</dc:creator>
<dc:creator>William F DeGrado</dc:creator>
<dc:creator>Matt Thomson</dc:creator>
<dc:creator>Krishna Garikipati</dc:creator>
<dc:creator>Dario Boffelli</dc:creator>
<dc:creator>Ophir D Klein</dc:creator>
<dc:creator>Zev J Gartner</dc:creator>
<dc:date>2024-05-23</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Patterning and folding of intestinal villi by active mesenchymal dewetting</dc:title>
<dc:identifier>pmid:38781967</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.039</dc:identifier>
</item>
<item>
<title>gNR4Aly Link Bridging Cellular Metabolism, Lactylation, and Vascular Calcification</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38781306/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 May 24;134(11):1448-1450. doi: 10.1161/CIRCRESAHA.124.324572. Epub 2024 May 23.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38781306/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38781306</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.324572>10.1161/CIRCRESAHA.124.324572</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38781306</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Rolando A Cuevas</dc:creator>
<dc:creator>Parya Behzadi</dc:creator>
<dc:creator>Cynthia St Hilaire</dc:creator>
<dc:date>2024-05-23</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>gNR4Aly Link Bridging Cellular Metabolism, Lactylation, and Vascular Calcification</dc:title>
<dc:identifier>pmid:38781306</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.324572</dc:identifier>
</item>
<item>
<title>Correction to: ORAI1 Activates Proliferation of Lymphatic Endothelial Cells in Response to Laminar Flow Through Krüppel-Like Factors 2 and 4</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38781305/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 May 24;134(11):e176. doi: 10.1161/RES.0000000000000673. Epub 2024 May 23.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38781305/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38781305</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000673>10.1161/RES.0000000000000673</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38781305</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:date>2024-05-23</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Correction to: ORAI1 Activates Proliferation of Lymphatic Endothelial Cells in Response to Laminar Flow Through Krüppel-Like Factors 2 and 4</dc:title>
<dc:identifier>pmid:38781305</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000673</dc:identifier>
</item>
<item>
<title>New Kid on the Block: GLI1+ Cells and Pulmonary Arterioles Neomuscularization</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38781304/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 May 24;134(11):1402-1404. doi: 10.1161/CIRCRESAHA.124.324574. Epub 2024 May 23.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38781304/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38781304</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.324574>10.1161/CIRCRESAHA.124.324574</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38781304</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Imad Al Ghouleh</dc:creator>
<dc:creator>Andres Pulgarin Rocha</dc:creator>
<dc:creator>Elena A Goncharova</dc:creator>
<dc:date>2024-05-23</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>New Kid on the Block: GLI1+ Cells and Pulmonary Arterioles Neomuscularization</dc:title>
<dc:identifier>pmid:38781304</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.324574</dc:identifier>
</item>
<item>
<title>RNA Sequencing Atherosclerosis Data Sets: Expanding Potential Therapeutic Targets</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38781303/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 May 24;134(11):1424-1426. doi: 10.1161/CIRCRESAHA.124.324239. Epub 2024 May 23.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38781303/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38781303</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.324239>10.1161/CIRCRESAHA.124.324239</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38781303</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Marina Sorrentino Hernandes</dc:creator>
<dc:creator>Kathy K Griendling</dc:creator>
<dc:date>2024-05-23</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>RNA Sequencing Atherosclerosis Data Sets: Expanding Potential Therapeutic Targets</dc:title>
<dc:identifier>pmid:38781303</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.324239</dc:identifier>
</item>
<item>
<title>Connection Between HIV and Mitochondria in Cardiovascular Disease and Implications for Treatments</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38781302/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>HIV infection and antiretroviral therapy alter mitochondrial function, which can progressively lead to mitochondrial damage and accelerated aging. The interaction between persistent HIV reservoirs and mitochondria may provide insight into the relatively high rates of cardiovascular disease and mortality in persons living with HIV. In this review, we explore the intricate relationship between HIV and mitochondrial function, highlighting the potential for novel therapeutic strategies in the...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 May 24;134(11):1581-1606. doi: 10.1161/CIRCRESAHA.124.324296. Epub 2024 May 23.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">HIV infection and antiretroviral therapy alter mitochondrial function, which can progressively lead to mitochondrial damage and accelerated aging. The interaction between persistent HIV reservoirs and mitochondria may provide insight into the relatively high rates of cardiovascular disease and mortality in persons living with HIV. In this review, we explore the intricate relationship between HIV and mitochondrial function, highlighting the potential for novel therapeutic strategies in the context of cardiovascular diseases. We reflect on mitochondrial dynamics, mitochondrial DNA, and mitochondrial antiviral signaling protein in the context of HIV. Furthermore, we summarize how toxicities related to early antiretroviral therapy and current highly active antiretroviral therapy can contribute to mitochondrial dysregulation, chronic inflammation, and poor clinical outcomes. There is a need to understand the mechanisms and develop new targeted therapies. We further consider current and potential future therapies for HIV and their interplay with mitochondria. We reflect on the next-generation antiretroviral therapies and HIV cure due to the direct and indirect effects of HIV persistence, associated comorbidities, coinfections, and the advancement of interdisciplinary research fields. This includes exploring novel and creative approaches to target mitochondria for therapeutic intervention.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38781302/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38781302</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.324296>10.1161/CIRCRESAHA.124.324296</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38781302</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Antentor O Hinton</dc:creator>
<dc:creator>Alhaji U N'jai</dc:creator>
<dc:creator>Zer Vue</dc:creator>
<dc:creator>Celestine Wanjalla</dc:creator>
<dc:date>2024-05-23</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Connection Between HIV and Mitochondria in Cardiovascular Disease and Implications for Treatments</dc:title>
<dc:identifier>pmid:38781302</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.324296</dc:identifier>
</item>
<item>
<title>Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38781301/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>People living with HIV have a 1.5- to 2-fold increased risk of developing cardiovascular disease. Despite treatment with highly effective antiretroviral therapy, people living with HIV have chronic inflammation that makes them susceptible to multiple comorbidities. Several factors, including the HIV reservoir, coinfections, clonal hematopoiesis of indeterminate potential (CHIP), microbial translocation, and antiretroviral therapy, may contribute to the chronic state of inflammation. Within the...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 May 24;134(11):1515-1545. doi: 10.1161/CIRCRESAHA.124.323891. Epub 2024 May 23.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">People living with HIV have a 1.5- to 2-fold increased risk of developing cardiovascular disease. Despite treatment with highly effective antiretroviral therapy, people living with HIV have chronic inflammation that makes them susceptible to multiple comorbidities. Several factors, including the HIV reservoir, coinfections, clonal hematopoiesis of indeterminate potential (CHIP), microbial translocation, and antiretroviral therapy, may contribute to the chronic state of inflammation. Within the innate immune system, macrophages harbor latent HIV and are among the prominent immune cells present in atheroma during the progression of atherosclerosis. They secrete inflammatory cytokines such as IL (interleukin)-6 and tumor necrosis-α that stimulate the expression of adhesion molecules on the endothelium. This leads to the recruitment of other immune cells, including cluster of differentiation (CD)8<sup>+</sup> and CD4<sup>+</sup> T cells, also present in early and late atheroma. As such, cells of the innate and adaptive immune systems contribute to both systemic inflammation and vascular inflammation. On a molecular level, HIV-1 primes the NLRP3 (NLR family pyrin domain containing 3) inflammasome, leading to an increased expression of IL-1β, which is important for cardiovascular outcomes. Moreover, activation of TLRs (toll-like receptors) by HIV, gut microbes, and substance abuse further activates the NLRP3 inflammasome pathway. Finally, HIV proteins such as Nef (negative regulatory factor) can inhibit cholesterol efflux in monocytes and macrophages through direct action on the cholesterol transporter ABCA1 (ATP-binding cassette transporter A1), which promotes the formation of foam cells and the progression of atherosclerotic plaque. Here, we summarize the stages of atherosclerosis in the context of HIV, highlighting the effects of HIV, coinfections, and antiretroviral therapy on cells of the innate and adaptive immune system and describe current and future interventions to reduce residual inflammation and improve cardiovascular outcomes among people living with HIV.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38781301/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38781301</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.323891>10.1161/CIRCRESAHA.124.323891</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38781301</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Laventa M Obare</dc:creator>
<dc:creator>Tecla Temu</dc:creator>
<dc:creator>Simon A Mallal</dc:creator>
<dc:creator>Celestine N Wanjalla</dc:creator>
<dc:date>2024-05-23</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease</dc:title>
<dc:identifier>pmid:38781301</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.323891</dc:identifier>
</item>
<item>
<title>HIV-Associated Cardiovascular Disease Pathogenesis: An Emerging Understanding Through Imaging and Immunology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38781300/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>Cardiac abnormalities were identified early in the epidemic of AIDS, predating the isolation and characterization of the etiologic agent, HIV. Several decades later, the causation and pathogenesis of cardiovascular disease (CVD) linked to HIV infection continue to be the focus of intense speculation. Before the widespread use of antiretroviral therapy, HIV-associated CVD was primarily characterized by HIV-associated cardiomyopathy linked to profound immunodeficiency. With increasing...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 May 24;134(11):1546-1565. doi: 10.1161/CIRCRESAHA.124.323890. Epub 2024 May 23.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cardiac abnormalities were identified early in the epidemic of AIDS, predating the isolation and characterization of the etiologic agent, HIV. Several decades later, the causation and pathogenesis of cardiovascular disease (CVD) linked to HIV infection continue to be the focus of intense speculation. Before the widespread use of antiretroviral therapy, HIV-associated CVD was primarily characterized by HIV-associated cardiomyopathy linked to profound immunodeficiency. With increasing antiretroviral therapy use, viral load suppression, and establishment of immune competency, the effects of HIV on the cardiovascular system are more subtle. Yet, people living with HIV still face an increased incidence of cardiovascular pathology. Advances in cardiac imaging modalities and immunology have deepened our understanding of the pathogenesis of HIV-associated CVD. This review provides an overview of the pathogenesis of HIV-associated CVD integrating data from imaging and immunologic studies with particular relevance to the HIV population originating from high-endemic regions, such as sub-Saharan Africa. The review highlights key evidence gaps in the field and suggests future directions for research to better understand the complex HIV-CVD interactions.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38781300/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38781300</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.323890>10.1161/CIRCRESAHA.124.323890</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38781300</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Jonathan A Hudson</dc:creator>
<dc:creator>Rashida A Ferrand</dc:creator>
<dc:creator>Samuel N Gitau</dc:creator>
<dc:creator>Marianne Wanjiru Mureithi</dc:creator>
<dc:creator>Pasquale Maffia</dc:creator>
<dc:creator>Shirjel R Alam</dc:creator>
<dc:creator>Anoop S V Shah</dc:creator>
<dc:date>2024-05-23</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>HIV-Associated Cardiovascular Disease Pathogenesis: An Emerging Understanding Through Imaging and Immunology</dc:title>
<dc:identifier>pmid:38781300</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.323890</dc:identifier>
</item>
<item>
<title>Cardiovascular Dynamics in HIV: The Influence of Adrenal Function and Nutritional Status</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38781299/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>This interdisciplinary review explores the intricate nexus between HIV infection, nutrition, adrenal gland function, and cardiovascular health, highlighting a critical aspect of HIV management often overlooked in current literature. With the advent of antiretroviral therapy, the life expectancy of people living with HIV has dramatically improved, transforming HIV into a manageable chronic condition. However, this success brings forth new challenges, notably an increased risk of cardiovascular...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 May 24;134(11):1566-1580. doi: 10.1161/CIRCRESAHA.124.323966. Epub 2024 May 23.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">This interdisciplinary review explores the intricate nexus between HIV infection, nutrition, adrenal gland function, and cardiovascular health, highlighting a critical aspect of HIV management often overlooked in current literature. With the advent of antiretroviral therapy, the life expectancy of people living with HIV has dramatically improved, transforming HIV into a manageable chronic condition. However, this success brings forth new challenges, notably an increased risk of cardiovascular diseases among people living with HIV. We examine the normal physiology of the adrenal gland, including its role in mineral metabolism, a crucial facet of nutrition. We discuss the evolution of knowledge tying adrenal pathology to cardiovascular disease. We explore the impact of HIV on adrenal gland findings from a gross pathology perspective, as well as the clinical impact of adrenal insufficiency in HIV. The review further elucidates the role of nutrition in this context, considering the double burden of undernutrition and obesity prevalent in regions heavily affected by HIV. By aggregating findings from longitudinal studies and recent clinical trials, the review presents compelling evidence of increased cardiovascular disease among people living with HIV compared with people without HIV. It highlights the critical role of the adrenal glands in regulating nutrient metabolism and its implications for cardiovascular health, drawing attention to the potential for dietary interventions and targeted therapies to mitigate these risks. This review urges a paradigm shift in the management of HIV, advocating for a holistic approach that incorporates nutritional assessment and interventions into routine HIV care to address the complex interplay between HIV, adrenal function, and cardiovascular health. Through this lens, we offer insights into novel therapeutic strategies aimed at reducing cardiovascular risk in people living with HIV, contributing to the ongoing efforts to enhance the quality of life and longevity in this population.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38781299/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38781299</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.323966>10.1161/CIRCRESAHA.124.323966</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38781299</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Anxious J Niwaha</dc:creator>
<dc:creator>James Brian Byrd</dc:creator>
<dc:date>2024-05-23</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Cardiovascular Dynamics in HIV: The Influence of Adrenal Function and Nutritional Status</dc:title>
<dc:identifier>pmid:38781299</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.323966</dc:identifier>
</item>
<item>
<title>HIV-Associated Hypertension: Risks, Mechanisms, and Knowledge Gaps</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38781298/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>HIV type 1 (HIV-1) is the causative agent of AIDS. Since the start of the epidemic, HIV/AIDS has been responsible for ≈40 million deaths. Additionally, an estimated 39 million people are currently infected with the virus. HIV-1 primarily infects immune cells, such as CD^(4+) (cluster of differentiation 4^(+)) T lymphocytes (T cells), and as a consequence, the number of CD^(4+) T cells progressively declines in people living with HIV. Within a span of ≈10 years, HIV-1 infection leads to the...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 May 24;134(11):e150-e175. doi: 10.1161/CIRCRESAHA.124.323979. Epub 2024 May 23.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">HIV type 1 (HIV-1) is the causative agent of AIDS. Since the start of the epidemic, HIV/AIDS has been responsible for ≈40 million deaths. Additionally, an estimated 39 million people are currently infected with the virus. HIV-1 primarily infects immune cells, such as CD<sup>4+</sup> (cluster of differentiation 4<sup>+</sup>) T lymphocytes (T cells), and as a consequence, the number of CD<sup>4+</sup> T cells progressively declines in people living with HIV. Within a span of ≈10 years, HIV-1 infection leads to the systemic failure of the immune system and progression to AIDS. Fortunately, potent antiviral therapy effectively controls HIV-1 infection and prevents AIDS-related deaths. The efficacy of the current antiviral therapy regimens has transformed the outcome of HIV/AIDS from a death sentence to a chronic disease with a prolonged lifespan of people living with HIV. However, antiviral therapy is not curative, is challenged by virus resistance, can be toxic, and, most importantly, requires lifelong adherence. Furthermore, the improved lifespan has resulted in an increased incidence of non-AIDS-related morbidities in people living with HIV including cardiovascular diseases, renal disease, liver disease, bone disease, cancer, and neurological conditions. In this review, we summarize the current state of knowledge of the cardiovascular comorbidities associated with HIV-1 infection, with a particular focus on hypertension. We also discuss the potential mechanisms known to drive HIV-1-associated hypertension and the knowledge gaps in our understanding of this comorbid condition. Finally, we suggest several directions of future research to better understand the factors, pathways, and mechanisms underlying HIV-1-associated hypertension in the post-antiviral therapy era.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38781298/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38781298</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.323979>10.1161/CIRCRESAHA.124.323979</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38781298</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Prem Prakash</dc:creator>
<dc:creator>Berwin Singh Swami Vetha</dc:creator>
<dc:creator>Rajasree Chakraborty</dc:creator>
<dc:creator>Tara-Yesomi Wenegieme</dc:creator>
<dc:creator>Sepiso K Masenga</dc:creator>
<dc:creator>Gladson Muthian</dc:creator>
<dc:creator>Muthukumar Balasubramaniam</dc:creator>
<dc:creator>Celestine N Wanjalla</dc:creator>
<dc:creator>Antentor O Hinton</dc:creator>
<dc:creator>Annet Kirabo</dc:creator>
<dc:creator>Clintoria R Williams</dc:creator>
<dc:creator>Azeez Aileru</dc:creator>
<dc:creator>Chandravanu Dash</dc:creator>
<dc:date>2024-05-23</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>HIV-Associated Hypertension: Risks, Mechanisms, and Knowledge Gaps</dc:title>
<dc:identifier>pmid:38781298</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.323979</dc:identifier>
</item>
<item>
<title>HIV and Cardiovascular Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38781297/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 May 24;134(11):1512-1514. doi: 10.1161/CIRCRESAHA.124.324805. Epub 2024 May 23.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38781297/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38781297</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.324805>10.1161/CIRCRESAHA.124.324805</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38781297</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Jeremiah M Afolabi</dc:creator>
<dc:creator>Annet Kirabo</dc:creator>
<dc:date>2024-05-23</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>HIV and Cardiovascular Disease</dc:title>
<dc:identifier>pmid:38781297</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.324805</dc:identifier>
</item>
<item>
<title>Cardiac and Renal Comorbidities in Aging People Living With HIV</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38781295/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>Contemporary World Health Organization data indicates that ≈39 million people are living with the human immunodeficiency virus. Of these, 24 million have been reported to have successfully accessed combination antiretroviral therapy. In 1996, the World Health Organization endorsed the widespread use of combination antiretroviral therapy, transforming human immunodeficiency virus infection from being a life-threatening disease to a chronic illness characterized by multiple comorbidities. The...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 May 24;134(11):1636-1660. doi: 10.1161/CIRCRESAHA.124.323948. Epub 2024 May 23.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Contemporary World Health Organization data indicates that ≈39 million people are living with the human immunodeficiency virus. Of these, 24 million have been reported to have successfully accessed combination antiretroviral therapy. In 1996, the World Health Organization endorsed the widespread use of combination antiretroviral therapy, transforming human immunodeficiency virus infection from being a life-threatening disease to a chronic illness characterized by multiple comorbidities. The increased access to combination antiretroviral therapy has translated to people living with human immunodeficiency virus (PLWH) no longer having a reduced life expectancy. Although aging as a biological process increases exposure to oxidative stress and subsequent systemic inflammation, this effect is likely enhanced in PLWH as they age. This narrative review engages the intricate interplay between human immunodeficiency virus associated chronic inflammation, combination antiretroviral therapy, and cardiac and renal comorbidities development in aging PLWH. We examine the evolving demographic profile of PLWH, emphasizing the increasing prevalence of aging individuals within this population. A central focus of the review discusses the pathophysiological mechanisms that underpin the heightened susceptibility of PLWH to renal and cardiac diseases as they age.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38781295/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38781295</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.323948>10.1161/CIRCRESAHA.124.323948</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38781295</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Keir McCutcheon</dc:creator>
<dc:creator>Unati Nqebelele</dc:creator>
<dc:creator>Lyle Murray</dc:creator>
<dc:creator>Teressa Sumy Thomas</dc:creator>
<dc:creator>Dineo Mpanya</dc:creator>
<dc:creator>Nqoba Tsabedze</dc:creator>
<dc:date>2024-05-23</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Cardiac and Renal Comorbidities in Aging People Living With HIV</dc:title>
<dc:identifier>pmid:38781295</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.323948</dc:identifier>
</item>
<item>
<title>Meet the First Authors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38781294/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 May 24;134(11):1400-1401. doi: 10.1161/RES.0000000000000675. Epub 2024 May 23.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38781294/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38781294</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000675>10.1161/RES.0000000000000675</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38781294</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:date>2024-05-23</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Meet the First Authors</dc:title>
<dc:identifier>pmid:38781294</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000675</dc:identifier>
</item>
<item>
<title>Exercise to Prevent Accelerated Vascular Aging in People Living With HIV</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38781293/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>Given advances in antiretroviral therapy, the mortality rate for HIV infection has dropped considerably over recent decades. However, people living with HIV (PLWH) experience longer life spans coupled with persistent immune activation despite viral suppression and potential toxicity from long-term antiretroviral therapy use. Consequently, PLWH face a cardiovascular disease (CVD) risk more than twice that of the general population, making it the leading cause of death among this group. Here, we...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 May 24;134(11):1607-1635. doi: 10.1161/CIRCRESAHA.124.323975. Epub 2024 May 23.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Given advances in antiretroviral therapy, the mortality rate for HIV infection has dropped considerably over recent decades. However, people living with HIV (PLWH) experience longer life spans coupled with persistent immune activation despite viral suppression and potential toxicity from long-term antiretroviral therapy use. Consequently, PLWH face a cardiovascular disease (CVD) risk more than twice that of the general population, making it the leading cause of death among this group. Here, we briefly review the epidemiology of CVD in PLWH highlighting disparities at the intersections of sex and gender, age, race/ethnicity, and the contributions of social determinants of health and psychosocial stress to increased CVD risk among individuals with marginalized identities. We then overview the pathophysiology of HIV and discuss the primary factors implicated as contributors to CVD risk among PLWH on antiretroviral therapy. Subsequently, we highlight the functional evidence of premature vascular dysfunction as an early pathophysiological determinant of CVD risk among PLWH, discuss several mechanisms underlying premature vascular dysfunction in PLWH, and synthesize current research on the pathophysiological mechanisms underlying accelerated vascular aging in PLWH, focusing on immune activation, chronic inflammation, and oxidative stress. We consider understudied aspects such as HIV-related changes to the gut microbiome and psychosocial stress, which may serve as mechanisms through which exercise can abrogate accelerated vascular aging. Emphasizing the significance of exercise, we review various modalities and their impacts on vascular health, proposing a holistic approach to managing CVD risks in PLWH. The discussion extends to critical future study areas related to vascular aging, CVD, and the efficacy of exercise interventions, with a call for more inclusive research that considers the diversity of the PLWH population.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38781293/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38781293</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.323975>10.1161/CIRCRESAHA.124.323975</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38781293</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Raymond Jones</dc:creator>
<dc:creator>Austin T Robinson</dc:creator>
<dc:creator>Lauren B Beach</dc:creator>
<dc:creator>Merry L Lindsey</dc:creator>
<dc:creator>Annet Kirabo</dc:creator>
<dc:creator>Antentor Hinton</dc:creator>
<dc:creator>Kristine M Erlandson</dc:creator>
<dc:creator>Nathaniel D M Jenkins</dc:creator>
<dc:date>2024-05-23</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Exercise to Prevent Accelerated Vascular Aging in People Living With HIV</dc:title>
<dc:identifier>pmid:38781293</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.323975</dc:identifier>
</item>
<item>
<title>A non-invasive gateway to identifying potential substrates for macro-reentrant ventricular tachycardia in tetralogy of Fallot</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38780021/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 23:ehae196. doi: 10.1093/eurheartj/ehae196. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38780021/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38780021</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae196>10.1093/eurheartj/ehae196</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38780021</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Paul Khairy</dc:creator>
<dc:date>2024-05-23</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>A non-invasive gateway to identifying potential substrates for macro-reentrant ventricular tachycardia in tetralogy of Fallot</dc:title>
<dc:identifier>pmid:38780021</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae196</dc:identifier>
</item>
<item>
<title>Atrial fibrillation and flutter: reiterating the need to 'Go hard, Go early'</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38780009/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 23:ehae029. doi: 10.1093/eurheartj/ehae029. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38780009/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38780009</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae029>10.1093/eurheartj/ehae029</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38780009</guid>
<pubDate>Thu, 23 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Aneesha Chauhan</dc:creator>
<dc:creator>Amitava Banerjee</dc:creator>
<dc:date>2024-05-23</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Atrial fibrillation and flutter: reiterating the need to 'Go hard, Go early'</dc:title>
<dc:identifier>pmid:38780009</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae029</dc:identifier>
</item>
<item>
<title>Reply: Intravascular Imaging for Complex Coronary Intervention</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38777519/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240524203945&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 May 28;83(21):e209. doi: 10.1016/j.jacc.2024.03.406.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38777519/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240524203945&v=2.18.0.post9+e462414">38777519</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.03.406>10.1016/j.jacc.2024.03.406</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38777519</guid>
<pubDate>Wed, 22 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Do-Yoon Kang</dc:creator>
<dc:creator>Jung-Min Ahn</dc:creator>
<dc:creator>Seung-Jung Park</dc:creator>
<dc:creator>Duk-Woo Park</dc:creator>
<dc:date>2024-05-22</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Reply: Intravascular Imaging for Complex Coronary Intervention</dc:title>
<dc:identifier>pmid:38777519</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.03.406</dc:identifier>
</item>





























</channel>
</rss>